Transcriptional profiling uncovers a network of cholesterol-responsive atherosclerosis target genes
- PMID: 18369455
- PMCID: PMC2265530
- DOI: 10.1371/journal.pgen.1000036
Transcriptional profiling uncovers a network of cholesterol-responsive atherosclerosis target genes
Abstract
Despite the well-documented effects of plasma lipid lowering regimes halting atherosclerosis lesion development and reducing morbidity and mortality of coronary artery disease and stroke, the transcriptional response in the atherosclerotic lesion mediating these beneficial effects has not yet been carefully investigated. We performed transcriptional profiling at 10-week intervals in atherosclerosis-prone mice with human-like hypercholesterolemia and a genetic switch to lower plasma lipoproteins (Ldlr(-/-)Apo(100/100)Mttp(flox/flox) Mx1-Cre). Atherosclerotic lesions progressed slowly at first, then expanded rapidly, and plateaued after advanced lesions formed. Analysis of lesion expression profiles indicated that accumulation of lipid-poor macrophages reached a point that led to the rapid expansion phase with accelerated foam-cell formation and inflammation, an interpretation supported by lesion histology. Genetic lowering of plasma cholesterol (e.g., lipoproteins) at this point all together prevented the formation of advanced plaques and parallel transcriptional profiling of the atherosclerotic arterial wall identified 37 cholesterol-responsive genes mediating this effect. Validation by siRNA-inhibition in macrophages incubated with acetylated-LDL revealed a network of eight cholesterol-responsive atherosclerosis genes regulating cholesterol-ester accumulation. Taken together, we have identified a network of atherosclerosis genes that in response to plasma cholesterol-lowering prevents the formation of advanced plaques. This network should be of interest for the development of novel atherosclerosis therapies.
Conflict of interest statement
Johan Björkegren and Jesper Tegnér are stock owners in Clinical Gene Networks AB. The company has filed a provisional patent on the atherosclerosis gene network presented in this study.
Figures
References
-
- Ong HT. The statin studies: from targeting hypercholesterolaemia to targeting the high risk patient. Qjm. 2005;98:599–614. - PubMed
-
- Grines CL. The role of statins in reversing atherosclerosis: What the latest regression studies show. J Interv Cardiol. 2006;19:3–9. - PubMed
-
- Tuomisto TT, Binder BR, Yla-Herttuala S. Genetics, genomics and proteomics in atherosclerosis research. Ann Med. 2005;37:323–332. - PubMed
-
- Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, et al. The sequence of the human genome. Science. 2001;291:1304–1351. - PubMed
-
- Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860–921. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
